Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-04
DOI
10.1007/s10585-020-10021-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA
- (2016) Yanting Zhang et al. MOLECULAR CANCER THERAPEUTICS
- EGFR and NF-κB: partners in cancer
- (2015) Kateryna Shostak et al. TRENDS IN MOLECULAR MEDICINE
- Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9
- (2014) WEI SUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
- (2013) Miao-Fen Chen et al. Molecular Cancer
- Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
- (2013) L K Nottingham et al. ONCOGENE
- Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling
- (2013) Robert Vander Broek et al. ORAL ONCOLOGY
- Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors
- (2012) B. J. M. Braakhuis et al. ANNALS OF ONCOLOGY
- Epithelial-Mesenchymal Transition Induced by TNF- Requires NF- B-Mediated Transcriptional Upregulation of Twist1
- (2012) C.-W. Li et al. CANCER RESEARCH
- Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature
- (2012) Guilherme Rabinowits et al. ORAL ONCOLOGY
- Epithelial to mesenchymal transition in head and neck squamous cell carcinoma
- (2012) Ashley Smith et al. ORAL ONCOLOGY
- MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
- (2011) L Sun et al. ONCOGENE
- Targeting NF- B in Mouse Models of Lung Adenocarcinoma
- (2011) C. Van Waes Cancer Discovery
- Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
- (2009) Yadi Wu et al. CANCER CELL
- Current and potential inflammation targeted therapies in head and neck cancer
- (2009) Frederick Wang et al. CURRENT OPINION IN PHARMACOLOGY
- The Current State of Head and Neck Cancer Gene Therapy
- (2009) Sufi Mary Thomas et al. HUMAN GENE THERAPY
- NF-κB in carcinoma therapy and prevention
- (2008) Matthew Brown et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Dysregulated molecular networks in head and neck carcinogenesis
- (2008) Alfredo A. Molinolo et al. ORAL ONCOLOGY
- Current concepts for the management of head and neck cancer: Chemotherapy
- (2008) Pol M. Specenier et al. ORAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started